ScripPublicly traded biopharmaceutical companies have faced a rough year for fundraising in 2025 with the amount of money raised across all financing types down significantly from 2024 levels during the
Generics BulletinDr Reddy’s and Alvotech have struck a further biosimilars alliance, announcing today a co-development partnership for a rival to Merck & Co/Merck Sharp & Dohme’s top-selling Keytruda (pembroli
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D
Generics BulletinAlvotech and Advanz have swelled their already considerable biosimilars partnership, striking a fresh agreement for a further three product candidates in Europe, including two for rare diseases. The n